The isoprenoid pathway in FRTL-5 thyroid cells was found to be deeply altered on transformation with v-K-ras. A dramatic overall reduction of protein prenylation was found in v Recent observations established a direct connection between the mevalonate pathway and transformation by ras. It was demonstrated that farnesol, a mevalonate-derived metabolite, is required for the modification that leads to the activation of the ras oncogene product p21 ras (1-5). The linkage of a farnesyl group to p21 ras
Recent observations established a direct connection between the mevalonate pathway and transformation by ras. It was demonstrated that farnesol, a mevalonate-derived metabolite, is required for the modification that leads to the activation of the ras oncogene product p21 ras (1) (2) (3) (4) (5) . The linkage of a farnesyl group to p21 ras , catalyzed by the protein farnesyltransferase (FTase), initiates a set of additional post-translational modifications that promote the anchorage of the Ras protein to the cell membrane, thus leading to the functional activation of this oncogene-encoded protein. An increased expression of normal or mutated ras has been detected in 40% of human cancers (6) , including anaplastic and follicular thyroid carcinoma (7) . It has been shown that v-K-ras oncogene down-regulates the expression of 3-hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme of isoprenoid biosynthesis, in FRTL-5 thyroid cells through the involvement of a novel cyclic AHPresponsive element site identified in its promoter (8, 9) . However, a possible effect of ras activity on protein prenylation and in particular on p21 ras farnesylation has not been investigated yet. To date, no evidence exists for the occurrence of alterations in protein prenylation after ras-induced cell transformation. The aim of this study was to analyze the prenylated proteins in normal and v-K-ras-transformed cells to assess whether such a correlation exists. We addressed this issue in FRTL-5 thyroid cells, a cell strain whose proliferation and differentiated functions, like iodide uptake and thyroglobulin synthesis, depend on thyrotropin (10) (11) (12) and, in the same cells, are transformed by (i) the Kirtsen-Moloney sarcoma virus (KiMol cells) (13, 14) , (ii) a temperature-sensitive mutant of v-K-ras (Ats cells) (15) , and (iii) the Harvey-ras oncogene (H-ras cells) (16) . FRTL-5 cells loose their differentiated functions on v-K-ras activation and represent a good model for investigations of possible correlations between K-ras activity and the isoprenoid pathway (9) .
Evidence for the occurrence of simultaneous regulation by K-ras oncogene on several enzymes of the isoprenoid biosynthesis and metabolism, i.e., mevalonate kinase (MK), farnesyl-PP synthase (FPP synthase), and FTase, concomitantly with a profoundly altered pattern of protein prenylation, will be presented. These effects may be considered as an example of cellular adaptation in response to K-ras-induced transformation and may result in the preferential farnesylation of the ras oncogene product p21 ras .
permissive; 39°C, nonpermissive) of Kirsten-murine sarcoma virus (15) . H-ras was derived from FRTL-5 cells transformed by Harvey ras oncogene (16) . TK-6 and MPTK-6 cells were derived, respectively, from a thyroid carcinoma and lung metastates of this tumor induced in propyl-thyouracylpretreated Fisher rats by the injection of a retrovirus carrying the v-K-ras oncogene (19 H]-MVA for 7 hr. Density of cell culture ranged between 1.5 and 2.0 ϫ 10 6 cells͞ml in 100-mm Petri dishes. Cells then were washed three times with ice-cold PBS, were scraped from the dish, and were lysed in hypotonic buffer. Equal amounts of each protein extract (Ϸ100 g) were analyzed by 12% SDS͞ PAGE as described (20) (21) (22) .
Immunoprecipitation and SDS͞PAGE.
[ 3 H]-MVA labeled cells were washed three times with PBS and were lysed in RIPA buffer [20 mM Tris͞150 mM NaCl͞1 mM EDTA͞0.5% (vol/vol) Nonidet P-40͞0.5% (wt/vol) Na deoxycholate͞0.1% (vol/vol) Trasylol͞0.2 mM phenylmethylsulfonyl fluoride, pH 7.4]. After 10 min on ice, the lysates were centrifuged at 12,000 ϫ g for 10 min, and supernatants were immunoprecipitated with 5 g of preimmune rat serum or anti-p21 ras mAb (Y13-259, Oncogene Science) followed by incubation with Protein A-Sepharose. Immunoprecipitates were washed three times with RIPA buffer and once with 100 mM Tris⅐Cl (pH 6.8) and then were dissolved in Laemmli loading buffer with 1 mM DTT before electrophoresis in a 12.5% SDS-polyacrylamide gel. Gels then were permeated with Amplify fluorographic enhancer (Amersham) and were dried and autoradiographed at Ϫ80°C. Protein Farnesylation Assay in Vitro. Cells were incubated with 10 M lovastatin for 6 hr at 37°C and then were washed with ice-cold PBS and were lysed in 50 mM Tris⅐HCl (pH 7.4), 10 mM DTT, 10 mM MgCl 2 , and 1 mM phenylmethylsulfonyl fluoride. The lysate was centrifuged at 100,000 ϫ g for 45 min, and 5 Ci of [ 3 H]-FPP were added to the supernatant. The mixture was incubated for 1 hr at 37°C, and proteins were precipitated with 9 vol of cold acetone and were analyzed by SDS͞PAGE.
Total RNA Preparation and Northern Blot Analysis. Total RNA was extracted by the guanidinium thiocyanate-acid phenol procedure. Total RNA (20 g) from each cell strain was loaded and separated on 1% agarose gel containing 2% formaldehyde and was blotted onto nylon membranes (Hybond-N, Amersham). Prehybridization (1 hr at 65°C), hybridization (16-18 hr at 65°C), and high stringency washes (1 hr at 65°C and 1 hr at 55°C) were carried out as reported (9) . An FPP synthase cDNA (CR39), kindly provided by P. A. Edwards (Univ. of California, Los Angeles), was used as radiolabeled probe (26) . Normalization was accomplished by using radiolabeled glyceraldehyde-phosphate dehydrogenase cDNA as reference probe. Cells derived from a thyroid carcinoma (TK-6 cells) induced in propyl-thyouracyl-pretreated rats by the injection of a retrovirus carrying the v-K-ras oncogene and from lung metastases of this tumor (MPTK-6 cells) displayed a pattern of [ 3 H]-MVA-labeled proteins identical to that of KiMol cells (Fig. 1) . Moreover, FRTL-5 cells transformed with a Kirstenmurine sarcoma virus variant carrying a temperature sensitive v-K-ras allele (Ats cells), exhibited, at the nonpermissive temperature for p21 ras activity (39°C), a pattern similar to FRTL-5 cells (Fig. 1) . On the other hand, when Ats cells were shifted over 7 days to the permissive temperature (33°C) for the ''transformed phenotype,'' they gradually lost [ 3 H]-MVAlabeled proteins until the 7 th day, when they showed p21 ras as the only prenylated protein (Fig. 1 ). This phenomenon required just 6-8 hr from the temperature shift to be evident and was not caused by a heat-shock mechanism because FRTL-5 cells did not change their prenylation pattern at either 33 or 39°C (data not shown). Densitometric analysis of the major prenylated proteins in Ats cells in experiments was performed at different times after p21 ras activation, so as to characterize the kinetics of the K-ras-induced changes in the protein prenylation profile, and revealed a different time-dependent disappearance of prenylation for the 48-and 21-to 25-kDa proteins. In fact, the former protein, previously identified as 2Ј, 3Ј-cyclic nucleotide 3Ј-phosphodiesterase (CNP) (22) , disap- (Fig. 1 A) .
RESULTS

Protein Prenylation and [
The changes in protein prenylation observed in KiMol cells was not caused by reduction of protein synthesis because the levels of proteins other than p21 ras , including other prenylated proteins, such as 2Ј, 3Ј-cyclic nucleotide 3Ј-phosphodiesterase and Rab5, are not varied in KiMol cells, Ats cells at 33°C, and H-ras cells with respect to FRTL-5 cells (data not shown). The expression of p21 ras in all cell lines transformed by either v-K-ras or Harvey-ras oncogenes was considerably higher than in FRTL-5 cells (data not shown), in which only a faint, 21-kDa band in SDS͞PAGE analyses of proteins immunoprecipitated by an anti-p21 ras mAb was found, in agreement with published data (13) (14) (15) (16) 19) . (Table 1) whereas HPLC analyses revealed a large increase (70%) of unprocessed [ 3 H]-MVA and a significant decrease of isopentenyl-tRNA in KiMol versus normal FRTL-5 cells (Table 1) . Moreover, the percentage of farnesol and geranylgeraniol released from prenylated proteins was respectively higher and lower in KiMol cells compared with FRTL-5 cells, thus leading to a reduced geranylgeraniol͞farnesol ratio ( (Table 2) . Similar results were obtained with Ats cells at 39°C (nontransformed) and at 33°C (transformed) (data not shown). Finally, in agreement with the overall decrease of geranylgeranylation of proteins described above, we found a sensible (2-to 3-fold) increase of the levels of unbound cytosolic Rab5 in KiMol cells (data not shown). and transformed cells, the expression of MK. Protein levels of MK, as assessed by immunoblot experiments with a polyclonal antibody to MK, were found to be decreased in KiMol and in Ats cells at 33°C when compared, respectively, to FRTL-5 cells and Ats cells at 39°C (Fig. 3) . On the other hand, H-ras cells showed MK levels similar to those of FRTL-5 cells (Fig. 3) .
Increased Protein Farnesyltransferase but not GeranylGeranyltransferase-I Activity in K-ras-and H-ras-Transformed FRTL-5 Cells. We analyzed the activity of FTase and protein geranyl-geranyltransferase-I in differentiated and transformed FRTL-5 cells. We observed a 2-to 3-fold increase in FPTase activity and no variation in geranyl-geranyltransferase I activity in K-ras-transformed cells in comparison with FRTL-5 cells (Fig. 4) . H-ras cells behaved like K-ras transformed cells by exhibiting a Ͻ2-fold increase in FTase activity and, again, no change in geranyl-geranyltransferase I activity. We next verified K-ras regulation of FTase activity by incorporating, using low density lipoprotein as physiological carriers, [ (Fig. 5A) whereas the geranylgeraniol͞farnesol ratio in prenylated proteins was decreased, and the percent of bound farnesol was increased in KiMol vs. FRTL-5 cells (Table 2) Increased Farnesyl-PP Synthase Expression in K-ras-and H-ras-Transformed FRTL5 Cells. We examined the expression of FPP synthase by analyzing its mRNA levels in differentiated and transformed FRTL-5 cells. Northern blot analysis showed that, in Ats cells incubated at 33°C and in KiMol cells, the levels of FPP synthase mRNA were 5-fold higher than those found in Ats cells grown at 39°C and in FRTL-5 cells, respectively (Fig. 6) . In H-ras cells, an up-regulation of FPP synthase mRNA levels also was observed (Fig. 6 ).
DISCUSSION
We presented data showing that K-ras oncogene activity affects protein prenylation. Transformation of FRTL-5 cells with v-K-ras caused a dramatic change in the pattern of prenylated proteins. An overall decrease of [ 3 H]-MVA-labeled proteins was observed in K-ras transformed cells whereas the ras-oncogene product p21 ras appeared still farnesylated. Our data strongly suggest that this phenomenon is related directly and specifically to K-ras activity. First, when this oncogene was activated in Ats cells (33°C), a pattern of prenylated proteins closely resembling that of KiMol cells was observed. In addition, cells derived from thyroid carcinoma, induced by expression of v-K-ras, and from lung metastases of this tumor displayed a similar profile of prenylated proteins. Conversely, FRTL-5 cells transformed by H-ras showed a pattern of prenylated proteins very similar to that found in nontransformed cells. There are at least two implications from this finding: (i) The alterations observed on transformation by K-ras provide an early and specific marker for K-ras transforming activity; 6-8 hours of oncogene activation were sufficient to observe an altered prenylation pattern; and (ii) these alterations represent an unprecedented example of how v-K-ras induces metabolic changes in the isoprenoid pathway.
The changes in the protein prenylation pathway observed here in v-K-ras transformed cells were found to be caused by reduction of geranylgeranylation and, only to a lesser extent, farnesylation of proteins, as assessed by HPLC analysis of the prenyl groups attached to proteins from FRTL-5, KiMol, and Ats cells labeled with either (Table 2 and data not shown). Indeed, a previous investigation (27) , carried out in Chinese hamster ovary cells, correlated (i) the appearance of a protein prenylation pattern similar to that observed here in v-K-ras-transformed cells and (ii) a drastic decrease of the geranylgeraniol͞farnesol ratio in total prenylated proteins, with decreasing concentrations of exogenous (27) . Here, we found that it is possible to reproduce a KiMol cell-like protein prenylation pattern also in nontransformed FRTL-5 cells by lowering the concentration of exogenous [ 3 H]-MVA (Fig. 2) . We found that the geranylgeraniol͞farnesol ratio in total prenylated proteins decreased with decreasing [ 3 H]-MVA concentrations in a way strikingly similar to that observed previously in Chinese hamster ovary cells (Table 2) . Moreover, both the percent of farnesol and the geranylgeraniol͞farnesol ratio in prenylated proteins from FRTL-5 cells incubated with a low [ 3 H]-MVA concentration became identical to those observed in KiMol cells (Table 2) . On the other hand, an increase of [ 3 H]-MVA concentration did not reverse the changes of protein prenylation observed in KiMol cells (Fig. 2) . Therefore, we decided to assess whether the changes in protein prenylation observed here were caused by some irreversible alteration in the isoprenoid pathway subsequent to v-K-ras activation and leading to (i) conserved or slightly reduced p21 ras and protein farnesylation and (ii) greatly reduced protein geranylgeranylation. On the basis of the data reported here, we suggest that these changes are caused by the following events: (i) Exogenous [ 3 H]-MVA, internalized at the same rate by normal and transformed FRTL-5 cells, is metabolized to a lower extent in the latter cells because of v-K-ras-induced down-regulation of MK, thus creating favorable conditions for selective prenylation of farnesylated proteins over geranylgeranylated proteins, in general, and of p21 ras , in particular (see above); (ii) concomitantly, to counterbalance the decreased availability of dimethylallyl-PP, the expression of FPP synthase is upregulated, thereby shunting the available dimethylallyl-PP to the synthesis of farnesyl-PP; and (iii) finally, the preferential prenylation of p21 ras is enhanced further by increasing the activity of the enzyme responsible for its farnesylation, i.e., FTase. It is possible that this latter event is in part a direct consequence of increased expression of p21 ras , i.e., one of the FTase substrates, as observed in rabbit reticulocyte lysates (28) . Overexpression of p21 ras may explain why this protein, under conditions of limited amounts of farnesyl-PP and increased FTase activity, is selected over other farnesylated proteins (e.g., 2Ј, 3Ј-cyclic nucleotide 3Ј-phosphodiesterase) for preferential farnesylation. Overexpression of p21 ras , however, it is not necessary nor is sufficient as a prerequisite to direct cells toward selective farnesylation because the latter can be obtained, albeit to a lesser extent, also in nontransformed FRTL-5 cells (by lowering [ ras also is increased. Also, up-regulation of either FPP synthase and͞or FTase alone would not be sufficient to cause the change in protein prenylation observed in transformed cells. In fact, H-ras transformed cells and Ats cells at 39°C, where increased expression͞activity, respectively, of FPP synthase and FTase or of FTase only were observed, did not exhibit preferential farnesylation of p21 ras . Indeed, this phenomenon is only observed in those transformed cells that exhibit impaired MK expression. Therefore, among the metabolic alterations that we observed, MK down-regulation appears to be related strictly with the alteration of protein prenylation. In summary, two types of v-K-ras-induced metabolic alterations contribute to direct transformed cells toward preferential farnesylation of p21 ras . First, the biosynthesis of all of the precursors necessary for protein prenylation must be down-regulated, so as to lead to a differential decrease of the overall protein prenylation and p21 ras farnesylation. In vivo, this is probably achieved by impairing the expression of MK as well as that of 3-hydroxy-3-methylglutaryl-CoA reductase, as described (9) . Subsequently, expression͞activity of FPP syn- thase and FTase are up-regulated to further increase the incorporation of farnesyl-PP into the overexpressed p21 ras .
From the above observations it follows that the use of Ats and H-ras cells in this study was important, not only inasmuch as it allowed, together with data from other tumoral cells, to establish that the changes in the protein prenylation profile observed in transformed cells were related specifically to v-K-ras activation, but also because it provided a clue as to which of the metabolic changes observed are related to p21 ras synthesis and which to p21 ras activity. In Ats cells, in fact, p21 ras intracellular concentration is increased at both permissive (33°C) and nonpermissive (39°C) temperatures, but the oncogene product is active only at the former. Because MK and FPP synthase expression were modified only at 33°C whereas FTase activity was increased at both temperatures, it is possible that, of the three enzymes studied, only FPP synthase and MK require both the synthesis and the activation of p21 ras for their expression to be modified. Conversely, the presence of high levels of p21 ras , rather than its activity (tumorigenicity), would be sufficient to observe-and, as suggested above, may be the cause of-the increase of FTase activity (28) . As for H-ras cells, the differences in the isoprenoid pathway described here between these and KiMol cells are intriguing, although different biological effects of the H-ras and v-K-ras oncogene products have been reported (29, 30) .
A possible consequence of the differential decrease of protein farnesylation observed in this study in transformed KiMol cells is that the cell distribution of farnesylated proteins-which depend in part on their prenyl chain for membrane anchoring-and particularly of geranylgeranylated proteins, also is modified. This, indeed, was found to be the case for Rab5, whose unbound levels were increased significantly in KiMol cells (data not shown). However, high amounts of Rab5 still were associated with membranes, suggesting that other post-translational modifications may occur in v-K-rastransformed cells to compensate for the loss of prenyl chains and prompting further studies in this direction. It is worthwhile mentioning that this kind of compensatory effects already have been shown to occur for prenylated oncogene products (31) .
In conclusion, the findings described herein provide a remarkable example of how v-K-ras oncogene may induce several modifications in the isoprenoid pathway and, in particular, a dramatic decrease in the expression of MK, ultimately leading to preferential farnesylation of p21 ras . To establish whether this phenomenon also results in an improved functional activation of p21 ras was beyond the scope of this study and remains a subject for speculation. It is possible that MK down-regulation leads to the decrease͞inactivation of some as yet unidentified mevalonate derivative and͞or isoprenylated protein that inhibit p21 ras activation in undifferentiated cells. Recent experiments performed with the rat seminiferous epithelium (31) have shown that changes in the protein prenylation pattern similar to those described here can be observed also during a physiological response, such as the meiotic stages of spermatocyte formation, and are accompanied by comparable increases of FTase activity. Therefore, our findings, by describing the transformation-related alteration of protein prenylation, may represent the starting point for future investigations on this new aspect of oncogene expression during both physiological and pathological responses.
